Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus.

Jung-Min YuWan-Ming ChenMing-Chih Chen Ben-Chang Shia Szu-Yuan Wu

Published in: Pharmaceuticals (Basel, Switzerland) (2023)

In patients diagnosed with type 2 diabetes, consistent utilization of statins (≥28 cumulative defined daily doses per year) was shown to have a beneficial effect on all-cause mortality. Moreover, the risk of all-cause mortality decreased as the cumulative defined daily dose per year of statin increased.

Keyphrases

cardiovascular disease
end stage renal disease
coronary artery disease
newly diagnosed
ejection fraction
chronic kidney disease
physical activity
prognostic factors
patient reported outcomes
high intensity